angiotensin ii has been researched along with Proteinuria in 275 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (18.18) | 18.7374 |
1990's | 50 (18.18) | 18.2507 |
2000's | 112 (40.73) | 29.6817 |
2010's | 57 (20.73) | 24.3611 |
2020's | 6 (2.18) | 2.80 |
Authors | Studies |
---|---|
Davenport, JB; Jackson-Crawford, A; Lemarie, E; Lennon, R; Lowe, M; Mironov, A; Naylor, RW | 1 |
Dugas, CM; Franco, M; Katsurada, A; Navar, LG; Satou, R | 1 |
Arditi, M; Bernstein, E; Bernstein, KE; Cao, DY; Leal, DN; Nishi, H; Nosaka, N; Saito, S; Shimada, K; Tatsumoto, N; Yamashita, M | 1 |
Bader, M; Chen, J; Fung, E; Huang, XR; Lan, HY; Meng, J; Ni, J; Penninger, JM; Yang, F; Yu, XQ | 1 |
Benetti, A; Girardi, ACC; Luchi, WM; Martins, FL; Seguro, AC; Sene, LB; Shimizu, MHM | 1 |
Huang, S; Jia, Z; Niu, Y; Shi, W; Wang, S; Yu, J; Zhang, A; Zhang, Y; Zhou, W | 1 |
Nangaku, M; Ross, MJ | 1 |
Gentile, O; Gonzalez, AA; Ichihara, A; Jensen, VB; Kuczeriszka, M; Mamenko, M; McDonough, AA; McLellan, M; Pochynyuk, OM; Prieto, MC; Reverte, V; Rosales, CB; Veiras, LC | 1 |
Pruszynski, J; Roehm, B; Simoni, J; Wesson, DE | 1 |
Chang, W; Li, J; Xu, N; Yuan, W; Zhang, W | 1 |
Li, H; Liang, J; Liu, L; Wang, Z; Wen, Y; Xu, Q; Zhou, P | 1 |
Chu, PH; Hsieh, TH; Huang, PH; Li, SY; Susztak, K; Tarng, DC | 1 |
Bautista, R; Escalante, B; Reyes-Pardo, H; Rios, A; Sánchez, D; Vargas-Robles, H | 1 |
Kittikulsuth, W; Looney, SW; Pollock, DM | 1 |
Chiou, TT; Hsu, CY; Huang, PC; Lee, CT; Lee, YT; Ng, HY; Tain, YL | 1 |
Llinas, MT; Loria, A; Reverte, V; Salazar, F; Salazar, FJ; Tapia, A | 1 |
Huang, L; Wu, W; You, YS | 1 |
Baylis, C; Cunningham, MW; Sasser, JM | 1 |
Duan, XC; Fang, ZH; Gao, JR; Wang, YZ; Wu, J; Xia, LZ; Yao, XM | 1 |
Bachtler, M; Bos, EM; Frenay, AR; Hillebrands, JL; Koning, AM; Kwakernaak, AJ; Leuvenink, HG; Navis, G; Pasch, A; Snijder, PM; van den Berg, E; van Goor, H | 1 |
A, L; Bai, Q; Liang, Y; Wang, Y; Wu, H; Zheng, D; Zheng, Y; Zhuang, Z | 1 |
A, LT; Bai, Q; Liang, YX; Wang, Y; Wu, HY; Zheng, DX; Zhuang, Z | 1 |
Chen, J; Hu, YJ; Peng, DF; Tang, SY | 1 |
Liang, J; Liu, L; Wang, Z; Wen, Y; Zhang, Y; Zhou, P | 1 |
Eisenreich, A; Herlan, L; Kreutz, R; Langer, S | 1 |
Feng, C; Guo, L; Jin, H; Li, Y; Yang, X | 1 |
Chen, J; Lin, SY; Long, Q; Ni, L; Yin, Y; You, L; Zhang, JY; Zhang, Q | 1 |
Ask, K; Carlisle, RE; Dickhout, JG; Krepinsky, JC; Lu, C; Lukic, D; Marway, MK; Mohammed-Ali, Z | 1 |
Bi, G; Cao, K; Fang, D; He, Y; Li, Z; Song, X; Wang, F; Wei, Y; Wu, J; Yang, J; Zhang, Z | 1 |
Fujigaki, Y; Fukasawa, H; Hishida, A; Huang, Y; Kitagawa, M; Misaki, T; Nakagawa, T; Nakamura, Y; Ohashi, N; Suzuki, F; Suzuki, H; Suzuki, S; Togawa, A; Yamamoto, T | 1 |
de Jong, PE; de Zeeuw, D; Dullaart, RP; Gansevoort, RT | 1 |
Liu, XP; Pang, YJ; Sun, SJ; Sun, ZJ; Wang, YB; Zhao, TT; Zheng, M; Zhu, WW | 1 |
Bravo, Y; Chavez, M; Johnson, RJ; Parra, G; Pons, H; Quiroz, Y; Rodriguez-Iturbe, B; Salazar, J | 1 |
Fukuda, Y; Iino, Y; Ishizaki, M; Katayama, Y; Kawachi, H; Masuda, Y; Mii, A; Shimizu, A | 1 |
Gao, J; Li, Q; Liu, BC; Xu, LM | 1 |
Jung, KH; Kim, SK; Lee, BC | 1 |
Hiramatsu, N; Hiromura, K; Ikeuchi, H; Kaneko, Y; Kopp, JB; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakurai, N; Shigehara, T; Takeuchi, S; Tomioka, M | 1 |
Hashimoto, T; Kawachi, H; Miyauchi, N; Otaki, Y; Shimizu, F; Suzuki, K | 1 |
Baer, L; Gallo, G; Haddy, FJ; Kumar, AR; Manger, WM; Reidy, JJ; Simchon, S; Stokes, MB | 1 |
Glover, PH; Reckelhoff, JF; Ryan, MJ; Sartori-Valinotti, JC; Venegas-Pont, M | 1 |
Hao, LY; Hao, XQ; Li, XH; Yang, DL; Yuan, ZB; Zhang, HG | 1 |
Kutina, AV; Natochin, IuV; Shakhmatova, EI | 1 |
Border, WA; Huang, Y; Noble, NA; Zhang, J | 1 |
Fogo, AB; Han, JY; Kon, V; Ma, LJ; Naito, T; Tang, Y; Yang, H; Zuo, Y | 1 |
Macconi, D | 1 |
Newaz, M; Oyekan, A; Yousefipour, Z | 1 |
Bilan, VP; Jackson, EK; Tofovic, DS | 1 |
Botros, FT; LeBlanc, RM; Navar, LG | 1 |
Cervenka, L; Husková, Z; Kramer, HJ; Kujal, P; Mrázová, I; Rakusan, D; Thumová, M; Vanecková, I; Vanourková, Z; Vernerová, Z | 1 |
Glassock, RJ | 1 |
Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A | 1 |
Ahmad, S; Brosnihan, KB; Ferrario, CM; Habibi, J; Sowers, JR; Tilmon, RD; Varagic, J | 1 |
Ahn, SY; Ahn, YM; Chung, JH; Kang, SW; Kim, SD; Kim, SK; Lee, BC; Lee, SH | 1 |
Arribas, I; Bosch, RJ; Bover, J; Esbrit, P; Izquierdo, A; Ortega, A | 1 |
Červenka, L; Hammock, BD; Honetschlägerová, Z; Husková, Z; Hwang, SH; Imig, JD; Kopkan, L; Kramer, HJ; Sporková, A; Tsai, HJ; Vaňourková, Z | 1 |
Huang, LY; Su, S; Wang, TC; Yang, MC; Yeh, HL | 1 |
Cai, L; Guo, QY; Li, B; Liu, N; Ma, FZ; Miao, LN; Xu, ZG | 1 |
Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH | 1 |
Kim, HJ; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND | 1 |
Hernández-Fonseca, JP; Mosquera, J; Muñoz, M; Pedreañez, A; Rincón, J; Viera, N | 1 |
do Carmo, Mda G; Einicker-Lamas, M; Lara, LS; Luzardo, R; Ortiz-Costa, S; Paixão, AD; Silva, PA; Vieira-Filho, LD; Vieyra, A | 1 |
Igata, H; Imanishi, M; Kawaguchi, N; Kuroita, T; Kusumoto, K; Nagaya, H; Nishigaki, N; Ojima, M; Sakamoto, H; Tsuboi, A; Yamaguchi, F | 1 |
Bakker, M; Berden, JH; Bindels, RJ; de Boer, RA; Faul, C; Flesche, J; Hamming, I; Hoenderop, JG; Kistler, AD; Möller, CC; Navis, G; Nijenhuis, T; Reiser, J; Sloan, AJ; van der Vlag, J; van Goor, H; Wetzels, JF | 1 |
Bandhlish, A; Chander, PN; Kumar, D; Magoon, S; Malhotra, A; Sagar, A; Salhan, D; Sayeneni, S; Singhal, PC; Torri, DD | 1 |
Kobori, H; Lara, LS; Majid, DS; McCormack, M; Navar, LG; Prieto, MC; Semprum-Prieto, LC; Shenouda, S | 1 |
Chen, C; Ding, G; Liang, W; Ren, Z; Singhal, PC; Yang, H | 1 |
Blackburn, MR; Dai, Y; Kellems, RE; Ning, C; Sun, H; Tao, L; Wang, W; Xia, Y; Yu, H; Zhang, W; Zhang, Y | 1 |
Ahmed, SB; Hemmelgarn, BR; MacRae, JM; Muruve, DA; Nicholl, DD; Sola, DY; Turin, TC | 1 |
Hongo, M; Ishizaka, N; Nagai, R; Saito, K; Sakamoto, A | 1 |
Asanuma, K; Fujisawa, Y; Hitomi, H; Kobori, H; Lei, B; Liu, Y; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Tomino, Y | 1 |
Benhamou, M; Berthelot, L; Camara, NO; Chemouny, JM; Demion, M; Flamant, M; Julian, BA; Mesnard, L; Monteiro, RC; Moura, IC; Novak, J; Paubelle, E; Raskova Kafkova, L; Tamouza, H; Tissandié, E; Tiwari, MK; Vrtovsnik, F; Walker, F | 1 |
Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV | 1 |
Loria, AS; Pollock, DM; Pollock, JS; Yamamoto, T | 1 |
Chen, HY; Heuchel, RL; Huang, XR; Lan, HY; Li, YQ; Liu, GX; Shi, YJ; Wei, L | 1 |
Devonald, MA; Karet, FE | 1 |
Benigni, A; Donadoni, C; Fassi, A; Gagliardini, E; Lepre, MS; Remuzzi, A; Remuzzi, G; Sangalli, F | 1 |
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L | 1 |
Fakhry, I; Gehr, TW; Ghosh, S; Haas, M; Quigg, RJ; Schoolwerth, AC; Sica, D | 1 |
Hulthén, UL | 1 |
Goto, A | 1 |
Ronco, P | 1 |
Fujita, T; Inagi, R; Kurokawa, K; Miyata, T; Nangaku, M; Shao, J; Yamada, K | 1 |
Duarte, J; Moreno, JM; Osuna, A; Rodríguez-Gómez, I; Sainz, J; Vargas, F; Wangensteen, R | 1 |
Mohanram, A; Toto, RD | 1 |
Abe, Y; Fukui, T; Hitomi, H; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Nishiyama, A; Rahman, M; Shokoji, T; Yao, L; Zhang, GX | 1 |
Ishizaka, N; Mitani, H; Nagai, R; Ohno, M; Saito, K | 1 |
Ardiles, L; Egido, J; Esteban, V; Justo, P; Mezzano, S; Ortiz, A; Ruiz-Ortega, M; Ruperez, M; Suzuki, Y | 1 |
Adam, AG; Jaimes, EA; Raij, L; Zhou, MS | 1 |
CUPPAGE, FE; DEODHAR, SD; GABLEMAN, E | 1 |
Chamorro, V; Duarte, J; O'Valle, F; Osuna, A; Sainz, J; Vargas, F; Wangensteen, R | 1 |
Boner, G; Erman, A; Gafter, U; Natif, N; Sclarovsky-Benjaminov, F; Sulkes, J; Van Dijk, DJ | 1 |
Arend, A; Aunapuu, M; Ots, M; Pechter, U; Suuroja, T | 1 |
Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR | 1 |
Hishida, A; Yasuda, H; Yonemura, K | 1 |
Kamper, AL; Karlsen, FM | 1 |
Remuzzi, G; Schieppati, A | 2 |
Cox, AJ; Gilbert, RE; Gow, RM; Holthofer, H; Kelly, DJ; Langham, RG | 1 |
Boonyen, M; Futrakul, N; Futrakul, P; Patumraj, S; Siriviriyakul, P; Tosukhowong, P | 1 |
Cao, B; Feng, QH; Li, S; Li, XZ | 1 |
Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU | 1 |
Ruilope, LM; Segura, J | 1 |
Alamartine, E | 1 |
Kobori, H; Navar, LG; Ozawa, Y; Prieto-Carrasquero, MC | 1 |
Catanzaro, DF; Chen, R; Hu, L; Laragh, JH; Merali, C; Sealey, JE; Shi, Y; Zhou, Y | 1 |
Iigaya, K; Kumagai, H; Onami, T; Saruta, T; Takimoto, C | 1 |
Azizi, M; Ménard, J | 1 |
Suzuki, H | 1 |
Avila-Casado, MC; Bautista, R; Coronel, I; Escalante, B; Romo, E; Soto, V; Vázquez, E; Villalón, CM | 1 |
Shimizu, F | 1 |
Ito, S; Jin, C | 1 |
Ishizaka, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M | 1 |
Aikawa, A; Arai, K; Hasegawa, A; Ishikawa, Y; Kawamura, S; Kawamura, T; Miyagi, M; Mizuiri, S; Ohara, T; Sakai, K; Shibuya, K | 1 |
Andrews, PM; Felder, RA; Hashimoto, S; Jose, PA; Katoh, T; Midorikawa, S; Sanada, H; Sasaki, M; Watanabe, T; Yatabe, J; Yoneda, M | 1 |
Fujita, T; Hayashi, M; Hirahashi, J; Hishikawa, K; Imai, N; Marumo, T; Saruta, T; Shimizu, N; Takase, O; Takayanagi, A | 1 |
Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB | 1 |
Gündüz, F; Kuru, O; Sentürk, UK | 1 |
Fujii, K; Iida, M; Matsumura, K; Oka, M; Oniki, H | 1 |
Boomsma, F; de Zeeuw, D; Deelman, LE; Henning, RH; Roks, AJ; van der Wouden, EA | 1 |
Hishida, A; Ikegaya, N | 1 |
Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M | 1 |
Cao, W; Knapp, RR; Lau, K; Ma, JX; Mott, R; Wang, JJ; Zhang, SX | 1 |
Abe, Y; Baba, R; Fan, YY; Fujita, M; Hosomi, N; Kimura, S; Kohno, M; Miyatake, A; Nagai, Y; Nishiyama, A; Sun, GP | 1 |
Gavras, H; Ribeiro, AB | 1 |
Dang, XQ; He, QN; He, XJ; Li, Z; Wu, XC; Yi, Z | 1 |
Hirokoshi, K; Ichinose, K; Kitayama, H; Maeshima, Y; Makino, H; Sugiyama, H; Takazawa, Y; Wu, Y; Yamamoto, Y; Yamasaki, Y | 1 |
Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M | 1 |
Berge, RK; Gudbrandsen, OA; Hultstrøm, M; Iversen, BM; Leh, S; Monica Bivol, L; Vågnes, Ø | 1 |
Chan, CM; Lau, YK; Wong, KS; Woo, KT | 1 |
Hostetter, TH; Rosenberg, ME | 2 |
Adler, GK; Burr, D; Guo, C; Jonasson, L; Kikuchi, T; Martinez-Vasquez, D; Mayoral, S; Oestreicher, EM; Ricchiuti, V; Roubsanthisuk, W; Seely, EW; Yao, T | 1 |
Rump, LC | 1 |
Dworkin, LD; Gong, R; Rifai, A; Tolbert, EM; Yu, C | 1 |
Kobori, H; Ozawa, Y | 1 |
Llinas, MT; Loria, A; Reverte, V; Saez, F; Salazar, F; Salazar, FJ | 2 |
Ishiguro, K; Itoh, H; Sakamaki, Y; Saruta, T; Sasamura, H | 1 |
Hercule, H; Newaz, M; Oyekan, A; Truong, L; Yousefipour, Z | 1 |
Ichihara, A; Inagami, T; Itoh, H; Kaneshiro, Y; Nabi, AH; Nakagawa, T; Nishiyama, A; Sakoda, M; Suzuki, F; Takemitsu, T; Uddin, MN | 1 |
Fujioka, Y; Han, GD; Hashimoto, T; Kawachi, H; Koike, H; Miyauchi, N; Nakatsue, T; Shimizu, F; Suzuki, K | 1 |
Bravo, Y; Ferrebuz, A; Quiroz, Y; Rodríguez-Iturbe, B; Vaziri, ND | 1 |
Chappell, MC; Gallagher, PE; Groban, L; Pendergrass, KD; Pirro, NT; Yamaleyeva, LM | 1 |
Graciano, ML; Mitchell, KD; Mullins, JJ; Ortiz, RM | 1 |
Dusting, GJ; Jiang, F; Jones, GT | 1 |
Danchuk, S; Horvat, D; Puschett, JB; Sukhanov, S; Uddin, MN | 1 |
Bautista, R; Franco, M; González, L; Martínez, F; Monreal, R; Pacheco, U; Pérez-Méndez, O; Sánchez-Lozada, LG; Santamaría, J; Tapia, E | 1 |
Siragy, HM | 1 |
Abdulhag, UN; Helmchen, U; Hilgers, KF; Kirchhoff, F; Krebs, C; Maas, R; Meyer-Schwesinger, C; Stahl, RA; Wenzel, U; Wolf, G | 1 |
Chen, C; Ding, G; Franki, N; Jia, J; Liang, W; Singhal, PC; Zhu, J | 1 |
Wolf, G; Ziyadeh, FN | 1 |
Bradley, TJ; Cherney, DZ; Dekker, MG; Hébert, RL; Miller, JA; Nasrallah, R; Scholey, JW; Slorach, C; Sochett, EB | 1 |
Robertson, CR | 1 |
Ahlmén, J; Aurell, M; Blohmé, I; Brynger, H; Delin, K; Herlitz, H; Larsson, O | 1 |
DeVoe, SJ; O'Shaughnessy, R | 1 |
Maezawa, H; Odakura, T; Sugiyama, H; Uchimura, I | 1 |
Symonds, EM | 1 |
Bauman, JW | 2 |
Olson, JL; Rennke, HG; Venkatachalam, MA | 1 |
Broughton Pipkin, F; Symonds, EM | 3 |
Makino, J; Okamoto, H; Takano, M; Yayama, K | 1 |
Deen, WM; Lafayette, RA; Mayer, G; Meyer, TW; Myers, BD; Oliver, J | 1 |
Divish, BJ; Opgenorth, TJ; Polakowski, JS; Pollock, DM | 1 |
Sudo, J; Tamoto, K; Terui, J | 1 |
de Jong, PE; de Zeeuw, D; Gansevoort, RT; Redfield, A; Shahinfar, S | 1 |
Hutchison, FN | 1 |
Fogo, A | 1 |
de Jong, PE; de Zeeuw, D; Gansevoort, RT | 1 |
Gekle, M; Silbernagl, S | 1 |
Abe, K; Hiwatari, M; Kanazawa, M; Kohzuki, M; Sato, T; Watanabe, H; Yasujima, M; Yoshida, K | 1 |
Bellini, G; Bocin, E; Carraro, M; Cosenzi, A; Faccini, L; Franca, G; Piemontesi, A; Sacerdote, A | 1 |
Bruneval, P; Domergue, V; Fornes, P; Giudicelli, JF; Richer, C; Vacher, E | 1 |
Klahr, S | 1 |
Camargo, MJ; Campbell, WG; James, GD; Laragh, JH; Pecker, MS; Timmermans, PB; von Lutterotti, N | 1 |
Bauer, JH; Luger, AM; Reams, GP; Villarreal, D; Wang, X; Wu, Z | 1 |
Amore, A; Cacace, G; Coppo, R; De Filippi, PG; Gianoglio, B; Peruzzi, L; Picciotto, G; Piccoli, G; Roccatello, D | 1 |
Higaki, J; Kohara, K; Mikami, H; Ogihara, T; Okuda, N | 1 |
Benigni, A; Lapinski, R; Perico, N; Remuzzi, A; Remuzzi, G; Sangalli, F | 1 |
de Jong, PE; de Zeeuw, D; Gansevoort, RT; Hemmelder, MH | 1 |
Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD | 1 |
Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C | 1 |
Ahokas, RA; Friedman, SA; Lubarsky, SL; Sibai, BM | 1 |
Higaki, J; Kamide, K; Mikami, H; Moriguchi, A; Nagano, M; Nakano, N; Ogihara, T; Yo, Y; Yu, H | 1 |
Aiello, S; Konopka, K; Lapinski, R; Noris, M; Perico, N; Remuzzi, G | 1 |
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Wanibuchi, H; Yamanaka, S | 1 |
Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y | 1 |
Abbate, M; Benigni, A; Bruzzi, I; Capitanio, M; Corna, D; Donadelli, R; Oldroyd, S; Remuzzi, G; Zoja, C | 1 |
Benedetti, G; Benigni, A; Corna, D; Maffi, R; Remuzzi, G; Zoja, C | 1 |
Okumura, K; Ra, C; Ravetch, JV; Shirato, I; Suzuki, Y; Takai, T; Tomino, Y | 1 |
Bünten, B; Grabensee, B; Németh, R; Plum, J | 1 |
Fujimura, H; Nishiyama, S; Ohmachi, Y; Okumura, F; Toriumi, W; Yoneda, H | 1 |
Kawachi, H; Kimura, H; Nakamura, T; Obata, J; Ohno, S; Shimizu, F; Yoshida, Y | 1 |
Campistol, JM; Clesca, PH; Iñigo, P; Jimenez, W; Lario, S; Oppenheimer, F; Rivera, F | 1 |
Brooks, DP; Gandhi, M; Meyer, TW | 1 |
Meyers, CM | 1 |
Crkovská, J; Jirsa, M; Seráková, M; Stípek, S; Tesar, V; Vernerová, Z; Zima, T | 1 |
DE Jong, PE; DE Zeeuw, D; Navis, G; Wapstra, FH | 1 |
Aizawa, T; Ingelfinger, JR; Ishizaka, N; Mori, I; Nagai, R; Ohno, M; Taguchi, Ji; Tang, SS | 1 |
Baroni, EA; Coimbra, TM; Costa, RS; da Silva, CG | 1 |
Brenner, BM; Taal, MW | 1 |
Ito, M; Koyama, H; Maeda, T; Ohshige, A; Okamura, H; Yoshimura, T | 1 |
Croatt, AJ; Haugen, EN; Nath, KA | 1 |
Caridi, G; Ghiggeri, GM; Gusmano, R; Musante, L; Oleggini, R; Ravazzolo, R | 1 |
Bianchetti, MG; Teuffel, O; von Vigier, RO; Zberg, PM | 1 |
Brown, NJ; Donnert, E; Fogo, AB; Freeman, M; Ma, L; Nakamura, I; Nakamura, S; Vaughan, DE | 1 |
Burns, KD | 1 |
Hollenberg, NK | 1 |
Meyer, TW; Olson, JL; Sorooshian, M | 1 |
Abe, A; Hosoya, T; Imasawa, T; Kuriyama, S; Tomonari, H | 1 |
Benigni, A; Remuzzi, G | 1 |
Benigni, A; Perico, N; Remuzzi, G | 1 |
Duggan, KA; Macdonald, GJ; Yang, Y | 1 |
Cowley, AW; Dickhout, JG; Dumas, P; Greene, AS; Jacob, HJ; Kaldunski, ML; Roman, RJ | 1 |
Hayashi, M; Nakaya, H; Saruta, T; Sasamura, H | 1 |
Egido, J; Fortes, J; Gómez-Garre, D; Largo, R; Manzarbeitia, F; Tejera, N | 1 |
Joles, JA; Klok, PA; Kuipers, F; Navis, G; Smit-van Oosten, A; Stegeman, CA; Tiebosch, AT; van Goor, H | 1 |
Imura, Y; Matsuo, T; Nagano-Tsuge, H; Naka, T; Noda, M; Ohta, M; Sekiguchi, M; Shibouta, Y | 1 |
Miyauchi, N; Nakamura, Y | 1 |
Aizawa, T; Ingelfinger, JR; Ishizaka, N; Kurokawa, K; Mori, I; Nagai, R; Ohno, M; Tang, SS; Usui, S; Yamazaki, I | 1 |
Campbell, DJ; Mackie, FE; Meyer, TW | 1 |
Boner, G; Erman, A; Giler, S; van Dijk, DJ | 1 |
Thurston, H | 1 |
Aizawa, T; Amaki, T; Hirata, Y; Ishizaka, N; Mitani, H; Mori, I; Nagai, R; Nakamura, Y; Nangaku, M; Ohno, M; Sato, M; Suzuki, T; Usui, S | 1 |
Akimoto, K; Kangawa, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nishikimi, T; Tadokoro, K; Wang, X; Yoshihara, F | 1 |
Ardaillou, R; Baud, L; Cosyns, JP; Nivez, MP; Sraer, J; Verroust, P | 1 |
Ober, WB | 1 |
Kumagai, A; Matsuda, Y; Mikami, K; Moriya, H; Nishikawa, T; Takagi, T; Tamura, Y; Watanabe, M; Yamada, K | 1 |
Baylis, Ch; Bohrer, MP; Brenner, BM; Deen, WM | 1 |
Gepts, W; Lambert, PP; Potvliege, PR; Sadowski, J; Staroukine, M | 1 |
Arisz, L; Brentjens, JR; Donker, AJ; van der Hem, GK | 1 |
Hornych, H; Richet, G | 1 |
Bohrer, MP; Brenner, BM; Deen, WM; Robertson, CR | 1 |
Bernheim, JL; Myers, BD; Pokroy, N | 1 |
During, R; Kyank, H; Neumayer, E | 1 |
Boylan, JW; Eisenbach, GM; Liew, JB; Manz, N; Muir, P | 1 |
Broughton Pipkin, F; Craven, DJ; Symonds, EM | 1 |
Brücher, C; Spinelli, F | 1 |
Bahner, U; Geiger, H; Heidland, A; Hofmann, M; Kraus, I; Luft, FC; Palkovits, M | 1 |
Lafayette, RA; Mayer, G; Meyer, TW; Park, SK | 1 |
Callís, L; Fortuny, G; Nieto, J; Vila, A | 1 |
de Jong, PE; de Zeeuw, D; Heeg, JE; van der Hem, GK | 1 |
Harris, RC; Ichikawi, I | 1 |
Tao, WY; Wang, HY; Wang, L | 1 |
Ikawa, S; Suzuki, M | 1 |
de Jong, PE; de Zeeuw, D; van der Hem, GK | 1 |
Dunn, MJ | 1 |
Deen, WM; Ichikawa, I; Kon, V; Mitarai, T; Rennke, HG; Yoshioka, T | 1 |
Kaysen, GA; Krolewski, AS; Meyer, TW; Noth, RH; Schambelan, M | 1 |
Glassock, RJ; Kaizu, K; Marsh, D; Zipser, R | 1 |
Keane, WF; Raij, L | 1 |
Brown, JJ; Fraser, R; Kraszewski, A; Lever, AF; McIlwaine, GM; Morton, JJ; Robertson, JI; Tree, M; Weir, RJ | 1 |
Aparicio, M; Martin-Dupont, C; Wone, C | 1 |
Castenfors, J | 1 |
Fernandez, LA | 1 |
Bourgoignie, JJ; Donati, RM; Gallagher, NI; Kurz, L; Perry, HM; Warnecke, MA | 1 |
De Cesaris, R; Pirrelli, A | 2 |
Oelkers, W | 1 |
Bailey, JD; Balis, JU; Hartroft, P; Lynch, MJ; Sutherland, LE | 1 |
Hori, S; Kawai, H; Masumura, S; Mizuta, K; Nakata, K | 1 |
Hulme, B; Peart, WS; Pessina, AC | 2 |
Perry, EF; Perry, HM; Purifoy, JE | 1 |
Broyer, M; Godard, C; Royer, P; Vallotton, MB | 1 |
Fraser, R; Morton, JJ; Tree, M; Weir, RJ; Wilson, A | 1 |
Aloof, S; Becker, L; Grosswasser, Z; Mendelsohn, E; Najenson, T; Rosenfeld, JB; Solzi, P | 1 |
Chand, S; Daley, GL; Gant, NF; MacDonald, PC; Whalley, PJ | 1 |
Antonello, A; Baggio, B; Borsatti, A; Castellani, A; Corsini, A; Favaro, S; Todesco, S | 1 |
Pieri, R; Pirrelli, A | 1 |
Beaufils, M; Hornych, H; Richet, G | 1 |
Peart, WS; Pessina, AC | 1 |
39 review(s) available for angiotensin ii and Proteinuria
Article | Year |
---|---|
Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cytoskeletal Proteins; Ephrin-B1; Glomerular Filtration Rate; Humans; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Membrane Proteins; Nephrotic Syndrome; Nerve Tissue Proteins; Podocytes; Proteinuria; Receptor, Angiotensin, Type 1 | 2009 |
Targeting the renin angiotensin system for remission/regression of chronic kidney disease.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Models, Biological; Proteinuria; Remission Induction; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2010 |
Uremia (end-stage renal disease): how cost-effective are preventive strategies?
Topics: Angiotensin II; Antihypertensive Agents; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Mass Screening; Proteinuria | 2010 |
A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Disease Models, Animal; Humans; Hypertrophy; Kidney Diseases; Mice; Mice, Transgenic; Parathyroid Hormone-Related Protein; Proteinuria | 2011 |
Targeting the renin-angiotensin system in patients with renal disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Contraindications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Kidney Diseases; Proteinuria; Risk Factors; Vasoconstrictor Agents | 2002 |
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil | 2002 |
Nephrin: a pivotal molecule in proteinuria influenced by angiotensin II.
Topics: Albuminuria; Angiotensin II; Animals; Diabetic Angiopathies; Humans; Hypertension; Membrane Proteins; Proteins; Proteinuria | 2003 |
[The concept of nephroprotection: toward preventive and curative therapies for renal sclerosis].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Endothelins; Humans; Ischemia; Kidney; Kidney Failure, Chronic; Kidney Tubules, Proximal; Mice; Models, Animal; Proteinuria; Rats; Sclerosis; Transforming Growth Factor beta | 2002 |
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles | 2003 |
[Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Humans; Kidney Failure, Chronic; Myocardial Infarction; Proteinuria; Receptors, Angiotensin; Renin-Angiotensin System | 2003 |
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Topics: Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Proteinuria; Tetrazoles | 2003 |
Proteinuria and its consequences in renal disease.
Topics: Angiotensin II; Chronic Disease; Disease Progression; Fabry Disease; Humans; Hyperlipidemias; Hypertension, Renal; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Proteinuria | 2003 |
[IgA nephropathy].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biopsy; Diagnosis, Differential; Disease Progression; Glomerulonephritis, IGA; Hematuria; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney; Kidney Failure, Chronic; Prognosis; Proteinuria; Risk Factors; Time Factors | 2003 |
[Organ protection by angiotensin II receptor blockers].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cognition Disorders; Heart Failure; Humans; Hypertension; Kidney Diseases; Losartan; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Proteins; Proteinuria; Randomized Controlled Trials as Topic; Stroke; Tetrazoles | 2004 |
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Diabetic Nephropathies; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proteinuria; Rats; Renin-Angiotensin System; Ventricular Dysfunction, Left | 2004 |
[Renin-angiotensin-aldosterone system].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Kidney Failure, Chronic; Kidney Glomerulus; Polymorphism, Genetic; Proteinuria; Renal Dialysis; Renin-Angiotensin System | 2004 |
[Responsible genes for proteinuria and concept of the treatment for proteinuria].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Disease Models, Animal; Humans; Membrane Proteins; Nephrotic Syndrome; Proteins; Proteinuria; Rats | 2004 |
[RAS blockade].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nephrotic Syndrome; Proteinuria; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2004 |
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2006 |
[Molecular mechanisms of progression in renal failure].
Topics: Ammonia; Angiotensin II; Animals; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Nephrons; Oxidative Stress; Proteinuria; Renal Insufficiency | 2006 |
Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular System; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Kidney; Losartan; Proteinuria; Tetrazoles | 2006 |
Renal hemodynamics and permselectivity.
Topics: Angiotensin II; Animals; Diffusion; Disease Models, Animal; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Permeability; Pressure; Proteinuria; Rats | 1990 |
Secondary rise of albuminuria under AT1-receptor blockade--what is the potential role of aldosterone escape?
Topics: Albuminuria; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Humans; Mineralocorticoid Receptor Antagonists; Models, Biological; Proteinuria | 2007 |
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Topics: Angiotensin II; Diabetic Nephropathies; Endothelial Cells; Endothelium, Vascular; Humans; Kidney Glomerulus; Membrane Proteins; Models, Biological; Podocytes; Proteinuria; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2008 |
A review of transcapillary fluid and solute exchange in the renal glomerulus.
Topics: Angiotensin II; Animals; Capillary Permeability; Dextrans; Inulin; Kidney Glomerulus; Macromolecular Substances; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Serum Albumin; Solutions; Ultrafiltration | 1980 |
Hormonal modulation of proteinuria in the nephrotic syndrome.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Eicosanoids; Humans; Kinins; Nephrotic Syndrome; Proteinuria | 1993 |
Internephron heterogeneity of growth factors and sclerosis.
Topics: Angiotensin II; Animals; Glomerulosclerosis, Focal Segmental; Growth Substances; Humans; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Nephrectomy; Nephrons; Platelet-Derived Growth Factor; Proteinuria; Puromycin Aminonucleoside; Rats | 1994 |
Low-protein diets and angiotensin-converting enzyme inhibition in progressive renal failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dietary Proteins; Eicosanoids; Glomerular Filtration Rate; Humans; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Proteinuria; Rats; Renin-Angiotensin System | 1993 |
New insights into the pathogenesis of interstitial nephritis.
Topics: Angiotensin II; Animals; Antibody Formation; B-Lymphocytes; Chemokines; Disease Models, Animal; Humans; Immune Tolerance; Immunity, Cellular; Interferon-gamma; Kidney Tubules; Nephritis, Interstitial; Nitric Oxide; Proteinuria; Transforming Growth Factor beta | 1999 |
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |
Angiotensin II and its receptors in the diabetic kidney.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Kidney Glomerulus; Mice; Peptidyl-Dipeptidase A; Proteinuria; Rats; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin | 2000 |
Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Clinical Trials as Topic; Diabetes Mellitus; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney; Peptidyl-Dipeptidase A; Proteinuria; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance | 2000 |
Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Progression; Endothelin Receptor Antagonists; Endothelins; Humans; Kidney; Kidney Diseases; Proteinuria | 2001 |
Dual angiotensin II blockade: a promise of enhanced renal protection?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Synergism; Humans; Hypertension; Kidney Diseases; Proteinuria; Receptor, Angiotensin, Type 1; Tetrazoles | 2002 |
Experimental toxemia of pregnancy: review and speculation.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Dogs; Endocrine Glands; Female; Humans; Hypertension; Immunity; Ischemia; Kidney; Kidney Glomerulus; Liver; Placenta; Pre-Eclampsia; Pregnancy; Progesterone; Proteinuria; Rabbits; Rats; Renin; Uterus | 1977 |
Angiotensin actions in the kidney: renewed insight into the old hormone.
Topics: Angiotensin II; Animals; Cell Division; Glomerular Filtration Rate; Humans; Kidney; Proteinuria; Renal Circulation | 1991 |
[Angiotensin-converting enzyme inhibitors in the treatment of proteinuria].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Kidney; Proteinuria | 1991 |
Hemodynamic effects of glomerular permselectivity.
Topics: Angiotensin II; Capillary Permeability; Dietary Proteins; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Microcirculation; Proteinuria | 1990 |
Diabetic nephropathy: hemodynamic basis and implications for disease management.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fatty Acids, Unsaturated; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Proteinuria; Renin-Angiotensin System | 1989 |
13 trial(s) available for angiotensin ii and Proteinuria
Article | Year |
---|---|
Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cigarette Smoking; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Oxidative Stress; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Smoking Cessation | 2017 |
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apolipoprotein A-I; Apolipoproteins B; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Lipoproteins; Longitudinal Studies; Losartan; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Single-Blind Method; Triglycerides | 1995 |
Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Child; Drug Resistance; Drug Therapy, Combination; Female; Fosinopril; Glucocorticoids; Humans; Male; Nephrotic Syndrome; Peptidyl-Dipeptidase A; Prednisolone; Proteinuria; Renin | 2006 |
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta | 2006 |
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.
Topics: Adolescent; Adult; Angiotensin II; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male; Prostaglandins; Proteinuria; Pyrazoles; Renal Circulation; Sex Characteristics; Sulfonamides; Vasoconstrictor Agents; Vasodilation | 2008 |
Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
Topics: Albuminuria; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Imidazoles; Longitudinal Studies; Losartan; Male; Proteinuria; Renal Circulation; Single-Blind Method; Tetrazoles; Uric Acid | 1994 |
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Enalapril; Female; Humans; Hypertension; Imidazoles; Kidney; Losartan; Male; Middle Aged; Proteinuria; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 1994 |
Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition.
Topics: Adult; Angiotensin II; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Enalaprilat; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Proteinuria; Single-Blind Method; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow | 1996 |
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dextrans; Double-Blind Method; Erythrocyte Count; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inulin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Molecular Weight; p-Aminohippuric Acid; Particle Size; Potassium; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan | 1998 |
Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Topics: Adult; Aged; Angiotensin II; Antihypertensive Agents; Blood Pressure; Chronic Disease; Endothelins; Female; Fibrosis; Follow-Up Studies; Graft Rejection; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Losartan; Male; Middle Aged; Pilot Projects; Proteinuria; Transforming Growth Factor beta; Transplantation, Homologous; Vasoconstrictor Agents | 1999 |
Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease.
Topics: Adolescent; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Child; Child, Preschool; Chronic Disease; Female; Humans; Irbesartan; Kidney Diseases; Male; Proteinuria; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2000 |
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Proteinuria; Renal Circulation | 1991 |
223 other study(ies) available for angiotensin ii and Proteinuria
Article | Year |
---|---|
A novel nanoluciferase transgenic reporter measures proteinuria in zebrafish.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Captopril; Cisplatin; Gentamicins; Humans; Kidney Glomerulus; Nephritis, Hereditary; Nephrotic Syndrome; Proteinuria; Serum Albumin, Bovine; Zebrafish | 2022 |
Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Hypertension; Immunosuppression Therapy; Kidney; Kidney Diseases; Mycophenolic Acid; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2022 |
Overexpressed angiotensin-converting enzyme in neutrophils suppresses glomerular damage in crescentic glomerulonephritis.
Topics: Angiotensin II; Animals; Antigen-Antibody Complex; Complement C3b; Glomerulonephritis; Mice; Nephritis; Neutrophils; Proteinuria | 2022 |
Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Fibrosis; Gene Deletion; Hypertension, Renal; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephritis; Proteinuria; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2020 |
Urinary DPP4 correlates with renal dysfunction, and DPP4 inhibition protects against the reduction in megalin and podocin expression in experimental CKD.
Topics: Angiotensin II; Animals; Biomarkers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Fibrosis; Intracellular Signaling Peptides and Proteins; Kidney; Low Density Lipoprotein Receptor-Related Protein-2; Male; Membrane Proteins; Proteinuria; Rats, Wistar; Renal Insufficiency, Chronic; Retinol-Binding Proteins, Plasma; Signal Transduction; Sitagliptin Phosphate | 2021 |
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Electrolytes; Endothelial Cells; Glycine; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Kidney Glomerulus; Male; Mice; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Urine; Vascular Remodeling | 2021 |
ACE2 as therapy for glomerular disease: the devil is in the detail.
Topics: Angiotensin II; Animals; Diabetic Nephropathies; Humans; Kidney Glomerulus; Mice; Peptidyl-Dipeptidase A; Proteinuria | 2017 |
Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Epithelial Sodium Channels; Genetic Predisposition to Disease; Hypertension; Kidney Tubules, Collecting; Mice, Inbred C57BL; Mice, Knockout; Natriuresis; Phenotype; Proteinuria; Proton-Translocating ATPases; Receptors, Cell Surface; Renal Elimination; Renin; Sodium; Sodium Chloride, Dietary; Time Factors | 2017 |
Icariin improves acute kidney injury and proteinuria in a rat model of pregnancy‑induced hypertension.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Down-Regulation; Female; Flavonoids; Gestational Age; Hypertension, Pregnancy-Induced; Kidney; Membrane Proteins; NG-Nitroarginine Methyl Ester; Pregnancy; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System; Reproduction; Up-Regulation | 2017 |
Knocking down Cabin1 induces glomerular podocyte injury.
Topics: Actins; Angiotensin II; Animals; Apoptosis Regulatory Proteins; Cells, Cultured; Cytochromes c; Cytoskeleton; Gene Knockdown Techniques; Membrane Potentials; Mitochondria; Nephrectomy; Podocytes; Proteinuria; Rats; RNA, Small Interfering; Up-Regulation; Vasoconstrictor Agents | 2018 |
FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
Topics: Angiotensin II; Animals; Case-Control Studies; Cells, Cultured; Cytoskeleton; Disease Models, Animal; Focal Adhesion Kinase 1; Glomerular Filtration Barrier; Humans; Hypertension, Renal; Kidney; LIM-Homeodomain Proteins; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Nephritis; Neuropeptides; Podocytes; Proteinuria; rac1 GTP-Binding Protein; Transcription Factors | 2019 |
Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzhydryl Compounds; Blood Pressure; Disease Models, Animal; Glomerular Filtration Rate; Glucose; Glucosides; Hypertension; Losartan; Male; Microvilli; Proteinuria; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Endothelin ET(B) receptors contribute to sex differences in blood pressure elevation in angiotensin II hypertensive rats on a high-salt diet.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Synergism; Endothelin B Receptor Antagonists; Female; Hypertension; Male; Proteinuria; Pyrrolidines; Rats; Receptor, Endothelin B; Sex Characteristics; Sodium Chloride, Dietary | 2013 |
Renin angiotensin system blockade ameliorates lead nephropathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Gene Expression Regulation; Glomerular Filtration Rate; Kidney Diseases; Lead Poisoning; Losartan; Male; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Transforming Growth Factor beta | 2013 |
COX2 inhibition during nephrogenic period induces ANG II hypertension and sex-dependent changes in renal function during aging.
Topics: Aging; Angiotensin II; Animals; Blood Pressure; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Glomerular Filtration Rate; Hypertension; Kidney; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2014 |
Role of CD2-associated protein in podocyte apoptosis and proteinuria induced by angiotensin II.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Cells, Cultured; Cytoskeletal Proteins; Humans; Losartan; Podocytes; Proteinuria | 2014 |
Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Arginine; Arterial Pressure; Dinoprost; Disease Models, Animal; Down-Regulation; Humans; Hypertension; Injections, Subcutaneous; Kidney; Liver; Male; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Proteinuria; Rats, Sprague-Dawley; Recombinant Proteins; Relaxin; Thiobarbituric Acid Reactive Substances | 2014 |
[Protective effects and mechanism of congguiyishen capsules on diabetic nephropathy rats].
Topics: Angiotensin II; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Female; Hypoglycemic Agents; Kidney; Male; Plants, Medicinal; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin | 2014 |
Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage.
Topics: Angiotensin II; Animals; Base Sequence; DNA Primers; Hypertension; Kidney; Proteinuria; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Thiosulfates | 2014 |
Up-regulation of intrarenal renin-agiotensin system contributes to renal damage in high-salt induced hypertension rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Diet; Hypertension, Renal; Kidney; Losartan; Male; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary; Up-Regulation | 2014 |
[Up-regulation of intrarenal renin-angiotensin system contributes to renal damage in high-salt induced hypertension rats].
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Kidney; Male; Proteinuria; Rats; Rats, Inbred WKY; Real-Time Polymerase Chain Reaction; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Up-Regulation | 2015 |
Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Benzazepines; C-Reactive Protein; Cardio-Renal Syndrome; Case-Control Studies; Drug Synergism; Heptanoic Acids; Lipids; Male; Natriuretic Peptide, Brain; Proteinuria; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2015 |
Cabin1 localizes in glomerular podocyte and undergoes nuclear translocation during podocyte injury.
Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Calcineurin; Cells, Cultured; Kidney Glomerulus; Male; Mice; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Risk Factors | 2015 |
Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes.
Topics: Angiotensin II; Apoptosis; Caspase 3; Cell Survival; Cells, Cultured; Cytochromes c; Down-Regulation; Gene Expression Regulation; Humans; Membrane Glycoproteins; MicroRNAs; Phosphorylation; Podocytes; Proteinuria; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Transfection; Vasoconstrictor Agents | 2016 |
[In vivo study of the renoprotective effects of EGCG in diabetic db/db mice].
Topics: Angiotensin II; Animals; Catechin; Diabetes Mellitus; Kidney; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proteinuria; Proto-Oncogene Proteins c-akt | 2016 |
Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.
Topics: Angiotensin II; Animals; Cell Line; Diet, Protein-Restricted; Dietary Supplements; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Insulin Resistance; Keto Acids; Kidney; Male; Mesangial Cells; Nephrectomy; Oxidative Stress; Proteinuria; Proteomics; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Uremia | 2016 |
Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria.
Topics: Angiotensin II; Animals; Apoptosis; Biopsy; Blood Pressure; Disease Models, Animal; Endoplasmic Reticulum Stress; Fibrosis; Gene Expression Profiling; Humans; Hypertension; Inflammation; Male; Mice; Mice, Knockout; Nephrosclerosis; Phenylbutyrates; Proteinuria; Renal Insufficiency, Chronic; Transcription Factor CHOP; Transcriptome; Urinalysis | 2017 |
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Kidney; Male; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Telmisartan; Transforming Growth Factor beta | 2017 |
Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Antilymphocyte Serum; Blood Pressure; Gene Expression; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney; Male; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles | 2008 |
Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Disease Models, Animal; Female; Glycation End Products, Advanced; Hypertension; Kidney Cortex; Kidney Diseases; Male; NADPH Oxidases; Oxidative Stress; Phosphorylation; Platelet-Derived Growth Factor; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Transcription Factor RelA; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1 | 2009 |
Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70.
Topics: Angiotensin II; Animals; Autoimmunity; Cell Proliferation; Cells, Cultured; Disease Models, Animal; HSP70 Heat-Shock Proteins; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Sprague-Dawley; Salt Tolerance; T-Lymphocytes | 2008 |
Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Becaplermin; Biomarkers; Blood Pressure; Cell Proliferation; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Proteinuria; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Thy-1 Antigens | 2009 |
Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cattle; Cell Line; Culture Media, Conditioned; Gene Expression Regulation; Humans; Kidney Diseases; Kidney Tubules; Microscopy, Electron, Transmission; Peptidyl-Dipeptidase A; Proteinuria; RNA, Messenger; Serum Albumin, Bovine | 2009 |
Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy.
Topics: Abietanes; Angiotensin II; Animals; Blood Glucose; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Macrophages; Monocytes; Neutrophil Infiltration; Phenanthrenes; Protective Agents; Proteinuria; Rats; Transforming Growth Factor beta1 | 2009 |
Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluorescent Antibody Technique; Fluvastatin; Genes, Wilms Tumor; Glomerulosclerosis, Focal Segmental; Immunoenzyme Techniques; Indoles; Kidney; Male; Membrane Proteins; Mice; Mice, Transgenic; Microfilament Proteins; Nephrectomy; Phenotype; Podocytes; Proteinuria | 2009 |
Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cyclic GMP; Diastole; Dose-Response Relationship, Drug; Fibrosis; Glomerulosclerosis, Focal Segmental; Hemodynamics; Hypertension; Kidney; Kidney Glomerulus; Kidney Medulla; Organ Size; Proteinuria; Rats; Rats, Inbred Dahl; Sodium; Sodium Chloride, Dietary; Systole; Time Factors; Vascular Resistance; Vasoconstriction | 2009 |
Sexual dimorphism in the blood pressure response to angiotensin II in mice after angiotensin-converting enzyme blockade.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Catalase; Drug Synergism; Enalapril; F2-Isoprostanes; Female; Kidney Cortex; Male; Mice; Mice, Inbred C57BL; Proteinuria; Sex Characteristics; Superoxide Dismutase; Vasoconstrictor Agents | 2010 |
Prenatal exposure to lipopolysaccharide alters the intrarenal renin-angiotensin system and renal damage in offspring rats.
Topics: Angiotensin II; Animals; Blood Pressure; Creatine; Electrophoretic Mobility Shift Assay; Female; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Kidney Glomerulus; Lipopolysaccharides; NF-kappa B; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Proteinuria; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Thiocarbamates | 2010 |
[Influence of the angiotensin converting enzyme inhibition on the functional proteinuria in rats].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diuresis; Diuretics; Dose-Response Relationship, Drug; Enalaprilat; Female; Furosemide; Glomerular Filtration Rate; Kidney; Peptidyl-Dipeptidase A; Potassium; Proteinuria; Rats; Rats, Wistar; Vasotocin; Water | 2009 |
Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Proliferation; Cells, Cultured; Collagen Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Gene Expression Regulation; Glomerulonephritis; Infusion Pumps, Implantable; Infusions, Subcutaneous; Isoantibodies; Kidney; Male; Mesangial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Time Factors; Transforming Growth Factor beta1 | 2010 |
Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen; Disease Models, Animal; Fibrinolysin; Fibrosis; Glomerular Filtration Rate; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nephrectomy; Phosphorylation; Plasminogen Activator Inhibitor 1; Podocytes; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Time Factors | 2010 |
Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Creatinine; Endothelin-1; Indans; Kidney; Male; Natriuresis; Neprilysin; Nitrates; Propionates; Proteinuria; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Bilirubin exerts renoprotective effects in angiotensin II-hypertension.
Topics: Angiotensin II; Animals; Bilirubin; Blood Pressure; Body Weight; Drinking; Eating; Hypertension; Male; Proteinuria; Rats; Rats, Sprague-Dawley | 2010 |
Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fumarates; Heart Rate; Hypertension; Kidney Glomerulus; Losartan; Male; Proteinuria; Rats; Rats, Transgenic; Renin; Time Factors | 2010 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2010 |
Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.
Topics: Acute Kidney Injury; Adrenergic beta-1 Receptor Antagonists; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Ethanolamines; Male; Nebivolol; Nitric Oxide Synthase; Oxidative Stress; Proteinuria; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renal Circulation; Renin; Renin-Angiotensin System; Sodium Chloride | 2010 |
Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease.
Topics: Abietanes; Administration, Oral; Angiotensin II; Animals; Collagen Type IV; Creatinine; Disease Models, Animal; Drugs, Chinese Herbal; Kidney; Male; Phenanthrenes; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Salvia miltiorrhiza; Transforming Growth Factor beta1 | 2010 |
Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acids; Benzoates; Blood Pressure; Cytochrome P-450 CYP1A1; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Glomerular Filtration Rate; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mice; Promoter Regions, Genetic; Proteinuria; Rats; Renal Plasma Flow; Renin; Sodium; Time Factors; Urea | 2011 |
Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Databases as Topic; Diabetic Nephropathies; Disease Progression; Female; Guideline Adherence; Humans; Hypertension; Male; Middle Aged; Practice Patterns, Physicians'; Proteinuria; Taiwan; Vasoconstrictor Agents | 2011 |
Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
Topics: Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Cadherins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Gene Expression Regulation; Hydroxyeicosatetraenoic Acids; Kidney Glomerulus; Male; Organ Size; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Streptozocin; Up-Regulation | 2011 |
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brain; Captopril; Cytokines; Heart; Hydralazine; Hypertension; In Vitro Techniques; Insulin; Kidney; Leptin; Male; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Proteinuria; Rats; Rats, Inbred SHR; Ventricular Function, Left | 2011 |
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances | 2011 |
Proinflammatory role of angiotensin II in a rat nephrosis model induced by adriamycin.
Topics: Angiotensin II; Animals; Cholesterol; Disease Models, Animal; Doxorubicin; Endothelin-1; Fluorescent Antibody Technique; Inflammation; Inflammation Mediators; Kidney; Losartan; Male; Nephrosis; Proteinuria; Rats; Rats, Sprague-Dawley; Time Factors; Triglycerides; Weight Gain | 2011 |
Metabolic programming during lactation stimulates renal Na+ transport in the adult offspring due to an early impact on local angiotensin II pathways.
Topics: Angiotensin II; Animals; Biological Transport; Blood Pressure; Cell Membrane; Collagen; Cyclic AMP-Dependent Protein Kinases; Diet, Protein-Restricted; Eating; Female; Gene Expression Regulation, Enzymologic; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Kidney Tubules, Proximal; Lactation; Male; Malnutrition; Mothers; Pregnancy; Protein Kinase C; Proteinuria; Rats; Receptors, Angiotensin; Signal Transduction; Sodium; Sodium-Potassium-Exchanging ATPase; Time Factors; Weaning | 2011 |
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Blood Glucose; Blood Pressure; CHO Cells; Cricetinae; Cricetulus; Dogs; Hypertension; Hypertension, Renal; Imidazoles; Insulin; Male; Olmesartan Medoxomil; Oxadiazoles; Protective Agents; Proteinuria; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles | 2011 |
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcineurin; Calcium; Doxorubicin; Feedback, Physiological; Gene Expression Regulation; HEK293 Cells; Humans; Kidney Diseases; Mice; Models, Biological; NFATC Transcription Factors; Podocytes; Proteinuria; Rats; Renin; RNA, Messenger; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel | 2011 |
Adverse host factors exacerbate occult HIV-associated nephropathy.
Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensinogen; Animals; Biomarkers; Blood Pressure; Connective Tissue Growth Factor; Doxycycline; Epithelial-Mesenchymal Transition; Female; Gene Dosage; Genes, vpr; Host-Pathogen Interactions; Kidney; Male; Mice; Mice, Transgenic; Peptidyl-Dipeptidase A; Phenotype; Proteinuria; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Hypertension; Kidney; Male; NADPH Oxidases; Oxidative Stress; Peroxynitrous Acid; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Sodium Chloride, Dietary | 2012 |
Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Blotting, Western; Caveolae; Caveolin 1; CSK Tyrosine-Protein Kinase; Immunoprecipitation; Losartan; Membrane Proteins; Mice; Phosphorylation; Plasmids; Podocytes; Protein-Tyrosine Kinases; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Signal Transduction; src-Family Kinases; Transfection | 2012 |
Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.
Topics: Adult; Angiotensin II; Animals; Biopsy; Blood Pressure; Disease Progression; Endothelin-1; Female; Fibrosis; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Middle Aged; Organ Culture Techniques; Proteinuria; Renal Insufficiency, Chronic; Signal Transduction; Vasoconstrictor Agents | 2012 |
Increased urinary protein excretion in the "normal" range is associated with increased renin-angiotensin system activity.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Female; Hemodynamics; Humans; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Vascular Resistance | 2012 |
Reduction of renal lipid content and proteinuria by a PPAR-γ agonist in a rat model of angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Disease Models, Animal; Ferritins; Gene Expression Regulation; Heme Oxygenase-1; Hypertension; Iron; Kidney; Lipid Metabolism; Male; Pioglitazone; PPAR gamma; Proteinuria; Rats; Rats, Sprague-Dawley; Thiazolidinediones | 2012 |
N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cell Line; Desmin; Dihydropyridines; Hypertension; Male; Mice; Podocytes; Protective Agents; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System | 2012 |
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
Topics: Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antigen-Antibody Complex; Antigens, CD; Biopsy; Blood Pressure; Calcium; Cell Communication; Cell Proliferation; Cells, Cultured; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Inflammation Mediators; Interleukin-6; Male; MAP Kinase Signaling System; Mesangial Cells; Middle Aged; Phosphatidylinositol 3-Kinase; Phosphorylation; Podocytes; Proteinuria; Proto-Oncogene Proteins c-akt; Receptors, Transferrin; Renin-Angiotensin System; Time Factors; TOR Serine-Threonine Kinases; Young Adult | 2012 |
Preconditioning protects the heart in a prolonged uremic condition.
Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Urea; Uremia; Uric Acid; Ventricular Function, Left | 2012 |
Early life stress induces renal dysfunction in adult male rats but not female rats.
Topics: Age Factors; Aging; Angiotensin II; Animals; Anxiety, Separation; Arterial Pressure; Blood Pressure Monitoring, Ambulatory; Creatinine; Disease Models, Animal; Estradiol; Female; Hypertension; Kidney; Kidney Diseases; Male; Maternal Deprivation; Orchiectomy; Proteinuria; Rats; Rats, Inbred WKY; Sex Factors; Stress, Psychological; Telemetry; Testosterone | 2013 |
Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
Topics: Angiotensin II; Animals; Fibrosis; Gene Expression Regulation; Hypertension; Inflammation; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; MicroRNAs; NF-kappa B; Proteinuria; Signal Transduction; Smad3 Protein; Smad7 Protein; Sp1 Transcription Factor; Transforming Growth Factor beta | 2013 |
Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Collagen Type III; Disease Progression; Kidney Diseases; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Valine; Valsartan | 2002 |
The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury.
Topics: Angiotensin II; Animals; Cholesterol; Diet; Humans; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Sclerosis | 2002 |
Dual blockade of renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Kidney Diseases; Proteinuria; Renin-Angiotensin System | 2003 |
Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cytokines; Hypertension; Imidazoles; Interferon-gamma; Interleukin-4; Kidney; Male; Nephritis, Interstitial; Olmesartan Medoxomil; Polymerase Chain Reaction; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Tetrazoles | 2003 |
Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats.
Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Enzyme Inhibitors; Heart Rate; Hyperthyroidism; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Potassium; Proteinuria; Rats; Rats, Wistar; Sodium; Thyroxine | 2003 |
Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Blood Pressure; Creatinine; Cyclic N-Oxides; Cyclosporine; Hypertension; Immunosuppressive Agents; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Spin Labels; Tetrazoles; Valine; Valsartan | 2003 |
Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat.
Topics: Aging; Angiotensin II; Animals; Down-Regulation; Free Radical Scavengers; Gene Expression Regulation; Glucuronidase; Iron Chelating Agents; Iron Overload; Kidney; Klotho Proteins; Male; Membrane Proteins; Oxidative Stress; Phenylurea Compounds; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley | 2003 |
Renal expression of angiotensin type 2 (AT2) receptors during kidney damage.
Topics: Angiotensin II; Animals; Folic Acid; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Up-Regulation | 2003 |
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Isoprostanes; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride; Superoxides; Tetrazoles; Up-Regulation; Vasodilation | 2003 |
STUDIES ON THE MECHANISM OF EXPERIMENTAL PROTEINURIA INDUCED BY RENIN.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Angiotensins; Basement Membrane; Desoxycorticosterone; Electrons; Immune Sera; Kidney; Kidney Glomerulus; Microscopy; Microscopy, Electron; Pharmacology; Proteinuria; Rats; Renin; Research | 1964 |
Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cardiomegaly; Desoxycorticosterone; Endothelins; Hypertension; Isoprostanes; Kidney; Losartan; Male; Malondialdehyde; Proteinuria; Rats; Rats, Inbred SHR; Renin | 2004 |
Insulin and losartan reduce proteinuria and renal hypertrophy in the pregnant diabetic rat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Female; Hypertrophy; Hypoglycemic Agents; Insulin; Kidney; Losartan; Peptidyl-Dipeptidase A; Pregnancy; Pregnancy in Diabetics; Proteinuria; Rats | 2003 |
Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atenolol; Basement Membrane; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Hypertrophy; Kidney Failure, Chronic; Kidney Glomerulus; Losartan; Male; Microscopy, Electron; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Systole; Time Factors | 2003 |
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone | 2003 |
Distinct responses of membranoproliferative glomerulonephritis-related proteinuria to spironolactone with and without angiotensin II blockade.
Topics: Angiotensin II; Diuretics; Glomerulonephritis, Membranoproliferative; Humans; Proteinuria; Spironolactone | 2003 |
The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Disease Progression; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Proteinuria | 2003 |
Angiotensin II-induced proteinuria and expression of the podocyte slit pore membrane protein, nephrin.
Topics: Angiotensin II; Animals; Male; Membrane Proteins; Protein Biosynthesis; Proteins; Proteinuria; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2004 |
Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Calcium Channel Blockers; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Enalapril; Endothelial Cells; Glutathione; Humans; Kidney Function Tests; Kidney Glomerulus; Malondialdehyde; Nephrosis; Oxidative Stress; Phytotherapy; Plants, Medicinal; Platelet Aggregation Inhibitors; Proteinuria; Reishi; Renal Circulation; Treatment Outcome; Vasodilator Agents; Vitamin E | 2003 |
[Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibiotics, Antineoplastic; Biphenyl Compounds; Blood Urea Nitrogen; Collagen Type IV; Creatinine; Disease Models, Animal; Doxorubicin; Fibronectins; Growth Hormone; Immunohistochemistry; Irbesartan; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Serum Albumin; Tetrazoles; Transforming Growth Factor beta; Triglycerides | 2003 |
[Microalbuminuria is an early marker for increased morbidity and mortality].
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke | 2003 |
AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Hypertension; Imidazoles; Kidney; Kidney Tubules, Proximal; Male; Olmesartan Medoxomil; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Tetrazoles | 2004 |
Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Topics: Angiotensin II; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; Infusions, Intravenous; Kidney; Models, Cardiovascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; Time Factors; Troponin T; Vasoconstrictor Agents | 2004 |
Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Diuresis; Gene Expression Regulation; Imidazoles; Kidney; Ligation; Losartan; Male; Nephrectomy; Proteinuria; Pyridines; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renal Artery; RNA, Messenger | 2005 |
Iron dextran causes renal iron deposition but not renal dysfunction in angiotensin II-treated and untreated rats.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Ferritins; Heme Oxygenase (Decyclizing); Iron; Iron Overload; Iron-Dextran Complex; Kidney; Kidney Diseases; Male; Proteinuria; Rats; Rats, Sprague-Dawley | 2004 |
Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis--angiotensin II immunostaining and treatment outcome.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Child; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Male; Plasma Exchange; Proteinuria; Receptors, Angiotensin; Recurrence; Time Factors; Treatment Outcome | 2005 |
Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Diuresis; Histocytochemistry; Hypertension; Kidney; Male; Natriuresis; Oligonucleotides, Antisense; Potassium; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin | 2005 |
NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria.
Topics: Adenoviridae; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Carboxypeptidases; Dietary Proteins; Female; I-kappa B Proteins; Kidney; NF-kappa B; NF-KappaB Inhibitor alpha; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; RNA, Messenger | 2005 |
Angiotensin II inhibition attenuates postexercise proteinuria in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kallikrein-Kinin System; Losartan; Male; Physical Conditioning, Animal; Proteinuria; Rats; Rats, Wistar | 2005 |
Role of aldosterone in left ventricular hypertrophy in hypertension.
Topics: Adrenergic beta-Antagonists; Adrenocortical Adenoma; Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Echocardiography; Endomyocardial Fibrosis; Female; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Middle Aged; Proteinuria; Renin-Angiotensin System | 2006 |
Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Blood Pressure; Body Weight; Creatine; Creatinine; Doxorubicin; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Wistar | 2005 |
The CARI guidelines. Prevention of progression of kidney disease.
Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy | 2006 |
Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Topics: Adenoviridae; Angiotensin II; Animals; Blood Glucose; Blotting, Western; Body Weight; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Eye Proteins; Fibronectins; Genetic Therapy; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Metalloproteases; Nerve Growth Factors; Proteinuria; Rats; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Smad3 Protein; Streptozocin; Transforming Growth Factor beta1 | 2006 |
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatine; Hypertension; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 2006 |
Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Infusions, Parenteral; Kidney Diseases; Kidney Tubules; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, TIE-2; Vascular Endothelial Growth Factor A | 2006 |
Prevention of hypertension and organ damage in 2-kidney, 1-clip rats by tetradecylthioacetic acid.
Topics: Albuminuria; Angiotensin II; Animals; Blood Vessels; Dinoprost; Fatty Acids; Hypertension, Renovascular; Kidney; Liver; Male; Oleic Acid; Proteinuria; Rats; Rats, Wistar; Renin; RNA, Messenger; Sulfides; Vasoconstrictor Agents | 2006 |
ACE inhibitor use and the long-term risk of renal failure in diabetics.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Tretinoin | 2006 |
Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ovariectomy; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2006 |
Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chemokine CCL2; Chemokine CCL5; Dose-Response Relationship, Drug; Inflammation; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Tetrazoles; Vasoconstrictor Agents | 2007 |
Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Blotting, Western; Body Weight; Chemokine CCL2; Collagen; Electrophoretic Mobility Shift Assay; Hypertension, Renal; Kidney; Macrophages; Male; Monocytes; NF-kappa B; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Rho Factor; RNA, Messenger; Sesquiterpenes; Transcription Factor RelA; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2007 |
Sex and age differences of renal function in rats with reduced ANG II activity during the nephrogenic period.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Blood Pressure; Body Weight; Creatinine; Dehydration; Female; Glomerular Filtration Rate; Kidney; Male; Osmolar Concentration; Pregnancy; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Sex Characteristics | 2007 |
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Topics: Aging; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiovascular System; Critical Period, Psychological; Drug Administration Schedule; Enzyme Inhibitors; Hypertension; Kidney; Male; Mortality; NG-Nitroarginine Methyl Ester; Oxidative Stress; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles; Vasoconstrictor Agents | 2007 |
Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Creatinine; Dinoprost; Gene Expression; Glycerol; Hypoglycemic Agents; Kidney Glomerulus; Male; Nitric Oxide; Nitrites; PPAR gamma; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Thromboxane A2, Prostaglandin H2; Renal Artery; Sodium; Thiazolidinediones; Thromboxane A2; Thromboxane B2; Vasoconstriction | 2007 |
Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.
Topics: Age Factors; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Chlorocebus aethiops; COS Cells; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; MAP Kinase Signaling System; Prorenin Receptor; Proteinuria; Rats; Receptors, Cell Surface; Transforming Growth Factor beta1 | 2007 |
Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antibodies, Monoclonal; Capillaries; Female; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Membrane Proteins; Phosphoproteins; Podocytes; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sialoglycoproteins; Zonula Occludens-1 Protein | 2007 |
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Creatinine; Hypertension; Immunosuppressive Agents; Inflammation; Kidney Diseases; Lead; Lymphocytes; Macrophages; Male; Malondialdehyde; Mycophenolic Acid; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Superoxides; Transcription Factor RelA | 2007 |
Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Animals, Congenic; Blood Pressure; C-Reactive Protein; Cell Adhesion Molecules; Disease Models, Animal; Female; Fibrosis; Hypertension; Hypertrophy; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Membrane Proteins; Ovariectomy; Peptide Fragments; Proteinuria; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary | 2007 |
Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Cytochrome P-450 CYP1A1; Hematocrit; Hypertension, Malignant; Kidney; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Proteinuria; Rats; Renin; Sodium; Spironolactone | 2007 |
Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice.
Topics: Aging; Angiotensin II; Animals; Antioxidants; Aortic Rupture; Apolipoproteins E; Blood Pressure; Blotting, Western; Creatinine; Heme Oxygenase-1; Humans; Immunohistochemistry; Kidney; Kidney Function Tests; Male; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Oxidative Stress; Proteinuria; Thiobarbituric Acid Reactive Substances; U937 Cells | 2007 |
Effects of resibufogenin in experimental hypertension.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Bufanolides; Creatinine; Desoxycorticosterone; Disease Models, Animal; Hypertension, Renal; Male; Mineralocorticoids; Proteinuria; Rats; Rats, Inbred Strains; Sodium Chloride; Superoxides; Vasoconstrictor Agents | 2008 |
Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Kidney Cortex; Male; Proteinuria; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Vasoconstrictor Agents | 2008 |
Angiotensin AT1 and AT2 receptors--the battle for health and disease.
Topics: Angiotensin II; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values; Renal Circulation | 2007 |
Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Disease Models, Animal; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Male; Mice; Mineralocorticoids; Myocardium; Proteinuria; Vasoconstrictor Agents | 2008 |
Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Creatinine; Hypertension; In Situ Nick-End Labeling; Male; Membrane Proteins; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2008 |
Age- and sodium-sensitive hypertension and sex-dependent renal changes in rats with a reduced nephron number.
Topics: Age Factors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Dietary Proteins; Disease Models, Animal; Female; Glomerular Filtration Rate; Hypertension, Renal; Male; Nephrons; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Sex Factors; Sodium Chloride, Dietary | 2008 |
Captopril in hypertension after renal transplantation.
Topics: Adult; Angiotensin II; Captopril; Drug Resistance; Female; Humans; Hypertension; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Proline; Proteinuria; Renin; Time Factors | 1984 |
Clinical manifestations and diagnosis of pregnancy-induced hypertension.
Topics: Angiotensin II; Antigens; Antithrombin III; Bed Rest; Diastole; Endothelium; Factor VIII; Female; Humans; Hypertension; Kidney; Kidney Function Tests; Liver Function Tests; Posture; Pre-Eclampsia; Pregnancy; Proteinuria; Uric Acid; Vasodilation; von Willebrand Factor | 1984 |
Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria.
Topics: Aldosterone; Angiotensin II; Bed Rest; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Female; Furosemide; Humans; Male; Middle Aged; Proteinuria; Renin; Renin-Angiotensin System | 1981 |
Bed rest in pregnancy.
Topics: Angiotensin II; Bed Rest; Female; Fetal Death; Humans; Hypertension; Placenta Previa; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 1982 |
On the mechanism of angiotensin-induced proteinuria. I. Studies in aminonucleoside nephrotic rats and in saralasin blockade.
Topics: Angiotensin II; Animals; Electrophoresis, Polyacrylamide Gel; Female; Hemodynamics; Kidney; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Saralasin | 1981 |
Glomerular filtration of macromolecules: normal mechanisms and the pathogenesis of proteinuria.
Topics: Angiotensin II; Animals; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Macromolecular Substances; Nephritis; Nephrosis; Proteinuria | 1981 |
Factors affecting plasma angiotensin II concentration in labour.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Angiotensin II; Blood Pressure; Body Weight; Cesarean Section; Female; Humans; Labor, Obstetric; Maternal Age; Oxytocin; Parity; Pregnancy; Pregnancy Complications; Proteinuria; Time Factors | 1980 |
Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Basement Membrane; Benzimidazoles; Biphenyl Compounds; Glomerulonephritis; Kidney; Kidney Cortex; Kidney Glomerulus; Male; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1995 |
Effects of angiotensin II receptor blockade on remnant glomerular permselectivity.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Dextran Sulfate; Dextrans; Glomerular Filtration Rate; Imidazoles; Kidney Glomerulus; Losartan; Male; Nephrectomy; Permeability; Proteinuria; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1993 |
Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Diuresis; Dose-Response Relationship, Drug; Hypertension; Male; Nicotinic Acids; Nitric Oxide Synthase; Nitroarginine; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Time Factors | 1993 |
Proteinuric potentials of angiotensin II, [des-Asp1]-angiotensin II, and [des-Asp1, des-Arg2]-angiotensin II in rats.
Topics: Angiotensin II; Angiotensin III; Animals; Chemical Fractionation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Infusions, Intravenous; Kidney Glomerulus; Male; Proteinuria; Rats; Rats, Wistar | 1994 |
Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Glomerular Filtration Rate; Glycosuria; Hemodynamics; Imidazoles; Kidney Tubules; Losartan; Male; Ochratoxins; Proteinuria; Rats; Rats, Wistar; Receptors, Angiotensin; Renal Circulation; Tetrazoles | 1993 |
The augmented blood pressure response to chronic angiotensin II infusion in partially nephrectomized rats.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Infusions, Intravenous; Male; Natriuresis; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Urodynamics | 1993 |
Involvement of the renin angiotensin system in the pathogenesis of postexercise proteinuria.
Topics: Adult; Angiotensin II; Captopril; Exercise; Exercise Test; Female; Humans; Male; Proteinuria; Renin-Angiotensin System | 1993 |
Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Height; Body Weight; Brain; Cerebrovascular Disorders; Diuresis; Heart Rate; Hypertension; Incidence; Isoquinolines; Kidney; Male; Myocardium; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Risk Factors; Tetrahydroisoquinolines; Time Factors | 1993 |
Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Proteins; Body Weight; Brain; Chlorides; Creatinine; Diuresis; Hypertension; Imidazoles; Kidney; Losartan; Male; Myocardium; Organ Size; Osmolar Concentration; Potassium; Proteinuria; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Sodium; Tetrazoles | 1993 |
An evaluation of the renal protective effect of manidipine in the uninephrectomized spontaneously hypertensive rat.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Dihydropyridines; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Kidney; Male; Nephrectomy; Nitrobenzenes; Piperazines; Proteinuria; Rats; Rats, Inbred SHR | 1993 |
Angiotensin II local hyperreactivity in the progression of IgA nephropathy.
Topics: Adult; Aldosterone; Analysis of Variance; Angiotensin II; Captopril; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Proteinuria; Reference Values; Renal Circulation; Renin; Sodium | 1993 |
Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chromatography, High Pressure Liquid; Hydralazine; Hypertension; Indans; Kidney; Male; Proteinuria; Rats; Rats, Inbred SHR; Survival Analysis; Tetrazoles | 1993 |
Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Capillaries; Capillary Permeability; Ficoll; Irbesartan; Kidney Glomerulus; Male; Metabolic Clearance Rate; Molecular Weight; Particle Size; Perfusion; Proteinuria; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1996 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta | 1997 |
The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Female; Guanidines; Heart Rate; Hematocrit; Kinetics; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Pregnancy; Proteinuria; Rats; Rats, Inbred WKY | 1997 |
Renal effects of an angiotensin II antagonist in stroke-prone spontaneously hypertensive rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Imidazoles; Kidney; Kidney Function Tests; Kidney Glomerulus; Losartan; Organ Size; Proteinuria; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Tetrazoles; Tissue Embedding | 1997 |
Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney.
Topics: Angiotensin II; Animals; Azepines; Dexamethasone; Glucocorticoids; In Vitro Techniques; Kidney; Male; Perfusion; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proteinuria; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1997 |
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Glucose Tolerance Test; Imidazoles; Insulin; Male; Proteinuria; Pyridines; Rats; Rats, Inbred Strains | 1997 |
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Progression; Enalapril; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta | 1997 |
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antilymphocyte Serum; Blood Pressure; Cell Division; Creatinine; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Kidney; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1998 |
Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
Topics: Angiotensin II; Animals; Blood Pressure; Endothelin-1; Glomerulonephritis; Indoles; Kidney; Male; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Sprague-Dawley | 1998 |
Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Basement Membrane; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Female; Glomerulonephritis; Kidney Glomerulus; Macrophages; Male; Mice; Mice, Knockout; Monocytes; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, IgG; Tetrazoles | 1998 |
Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Calcium Channel Blockers; Cholesterol; Glucocorticoids; Hypertension; Imidazoles; Imidazolidines; Losartan; Male; Methylprednisolone; Nephrosis; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Verapamil | 1998 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cilazapril; Collagen; Disease Models, Animal; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 1999 |
Effects of eprosartan on glomerular injury in rats with reduced renal mass.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Drug Evaluation, Preclinical; Glomerulosclerosis, Focal Segmental; Imidazoles; Male; Nephrectomy; Proteinuria; Rats; Thiophenes; Vasoconstrictor Agents | 1999 |
[Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Doxorubicin; Eicosanoids; Enalapril; F2-Isoprostanes; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar | 1999 |
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Doxorubicin; Injections, Intraperitoneal; Lisinopril; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Time Factors | 2000 |
Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cell Line, Transformed; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glomerular Filtration Rate; Heart Rate; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemin; Hydralazine; Hypertension; Immunohistochemistry; Kidney Tubules, Proximal; Losartan; Norepinephrine; Oxidative Stress; Proteinuria; Protoporphyrins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta.
Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Doxorubicin; Endothelins; Female; Fibronectins; Heparin; Immunohistochemistry; Kidney Diseases; Kidney Glomerulus; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
Topics: Acetylglucosaminidase; Angiotensin II; Animals; Arginine; Blood Pressure; Consciousness; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Female; Infusions, Parenteral; Injections, Intravenous; Natriuresis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Proteinuria; Rats; Rats, Wistar | 1998 |
Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro.
Topics: Angiotensin II; Animals; Antioxidants; Blood Pressure; Blotting, Northern; Desoxycorticosterone; Disease Models, Animal; Enzyme Activation; Epithelial Cells; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hypertension, Renal; In Vitro Techniques; Kidney Failure, Chronic; Kidney Tubules; LLC-PK1 Cells; Male; Nephrectomy; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; RNA, Messenger; Swine; Thiobarbituric Acid Reactive Substances; Vasoconstrictor Agents | 2000 |
A DNA element in the alpha1 type III collagen promoter mediates a stimulatory response by angiotensin II.
Topics: Angiotensin II; Animals; Base Sequence; Cells, Cultured; Collagen; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Genetic Complementation Test; Heart Diseases; Kidney Diseases; Molecular Sequence Data; Muscle Fibers, Skeletal; Mutagenesis, Site-Directed; Myocardium; Plasmids; Promoter Regions, Genetic; Proteinuria; Rats; RNA, Messenger; Transcription Factors; Transfection; Vasoconstrictor Agents | 2000 |
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blotting, Northern; Creatinine; Disease Progression; Fibrosis; Gene Expression; Glomerulosclerosis, Focal Segmental; In Situ Hybridization; Kidney Glomerulus; Male; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spironolactone | 2000 |
Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Hypertension, Renal; Kidney; Kidney Function Tests; Losartan; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Renal Insufficiency; Sodium Chloride | 2000 |
Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Proteinuria | 2000 |
How renal cytokines and growth factors contribute to renal disease progression.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Disease Progression; Glomerular Filtration Rate; Growth Substances; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Proteinuria; Rats | 2001 |
Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Female; Hypertension; Metabolic Clearance Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Random Allocation; Rats; Rats, Inbred SHR; Receptors, Angiotensin | 2001 |
Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat.
Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Furosemide; Gene Transfer Techniques; Genetic Therapy; Genotype; Hypertension; Kidney Glomerulus; Kidney Medulla; Kidney Tubules; Necrosis; Norepinephrine; Proteinuria; Rats; Rats, Inbred BN; Rats, Inbred Dahl; Renal Artery; Renin; Sclerosis; Sodium Chloride; Sodium, Dietary; Vascular Resistance | 2001 |
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Gene Expression; Genetic Predisposition to Disease; Hydralazine; Hypertension; Indans; Kidney; Male; Nephrosclerosis; Proteinuria; Rats; Rats, Inbred SHR; Renin; Stroke; Tetrazoles; Time Factors; Vasodilator Agents | 2001 |
Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1.
Topics: Analysis of Variance; Angiotensin II; Animals; Atrophy; Cell Line; Endothelin-1; Epithelial Cells; Female; Kidney Cortex; Kidney Tubules; Nephrectomy; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred WKY | 2001 |
Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Glomerulonephritis; Hyperplasia; Kidney Transplantation; Lisinopril; Male; Oligopeptides; Postoperative Complications; Postoperative Period; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Renin-Angiotensin System; Tunica Intima | 2001 |
Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats).
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Disease Progression; Enalapril; Glomerular Mesangium; Male; Proteins; Proteinuria; Rats; Rats, Wistar; Rats, Zucker; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Triglycerides | 2001 |
Antiproteinuric effect of an angiotensin II receptor antagonist in membranous nephropathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Glomerulonephritis, Membranous; Humans; Kidney; Male; Middle Aged; Proteinuria | 2001 |
Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration.
Topics: Acetylglucosaminidase; Angiotensin II; Animals; Blood Pressure; Creatinine; Ferritins; Heart Rate; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemodynamics; Iron; Kidney; Kidney Cortex; Kidney Medulla; Kidney Tubules; Membrane Proteins; Mice; Mice, Knockout; Proteinuria; Rats; Urothelium | 2002 |
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bradykinin; Creatinine; Enalapril; Kidney; Losartan; Male; Nephrectomy; Nifedipine; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Vasodilator Agents | 2002 |
Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Female; Hypoglycemic Agents; Insulin; Kidney; Lung; Organ Size; Peptidyl-Dipeptidase A; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Pregnancy, Animal; Proteinuria; Rats; Rats, Wistar; Reference Values; Uterus | 2001 |
In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage.
Topics: Angiotensin II; Animals; Creatinine; Down-Regulation; Gene Transfer Techniques; Genetic Therapy; Glucuronidase; Hemodynamics; Hypertension, Renal; Kidney; Klotho Proteins; Male; Membrane Proteins; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vasoconstrictor Agents | 2002 |
Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.
Topics: Adrenomedullin; Angiotensin II; Animals; Creatinine; Drug Implants; Glomerulonephritis; Hormones; Hypertension; Kidney; Male; Peptides; Proteinuria; Rats; Rats, Inbred Dahl; Renal Insufficiency; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride; Time Factors; Transforming Growth Factor beta | 2002 |
High affinity binding of 125I-angiotensin II to rat glomerular basement membranes.
Topics: Angiotensin II; Animals; Antibodies; Basement Membrane; Creatinine; Female; Iodine Radioisotopes; Kidney Glomerulus; Proteinuria; Rats; Receptors, Angiotensin; Receptors, Cell Surface | 1977 |
Corticoid effects on angiotensin- and norepinephrine-induced proteinuria in rats.
Topics: Aldosterone; Angiotensin II; Animals; Dexamethasone; Female; Inulin; Norepinephrine; p-Aminohippuric Acid; Proteinuria; Rats; Sodium | 1979 |
Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Indomethacin; Isoelectric Focusing; Kallikreins; Middle Aged; Molecular Weight; Potassium; Proteinuria; Renin; Sodium | 1979 |
Determinants of glomerular permselectivity: Insights derived from observations in vivo.
Topics: Albuminuria; Angiotensin II; Animals; Blood Proteins; Capillary Permeability; Dextrans; Dogs; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Macromolecular Substances; Molecular Weight; Proteinuria; Rabbits; Rats; Renin; Serum Albumin; Swine | 1977 |
Urea-induced proteinuria: a new experimental model.
Topics: Angiotensin II; Animals; Disease Models, Animal; Dogs; Female; Inulin; Kidney Glomerulus; Male; Proteinuria; Urea | 1978 |
Pregnancy hypertension, parity, and the renin-angiotensin system.
Topics: Adult; Angiotensin II; Female; Humans; Hypertension; Parity; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Renin; Time Factors | 1978 |
Treatment of the nephrotic syndrome with indomethacin.
Topics: Angiotensin II; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Indomethacin; Kidney; Nephrotic Syndrome; Proteinuria; Regional Blood Flow; Renin; Serum Albumin; Substance Withdrawal Syndrome | 1978 |
Dissociated effect of sodium intake on glomerular and pressor responses to angiotensin.
Topics: Angiotensin II; Animals; Blood Pressure; Capillaries; Dose-Response Relationship, Drug; Drug Interactions; Kidney Glomerulus; Male; Proteinuria; Rats; Sodium | 1977 |
Mechanism of angiotensin II-induced proteinuria in the rat.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Proteins; Capillaries; Dextrans; Female; Glomerular Filtration Rate; Inulin; Kidney; Kidney Glomerulus; Male; Models, Biological; Proteinuria; Rats; Regional Blood Flow | 1977 |
[Influence of indomethacin on the course of glomerulonephritis].
Topics: Adult; Angiotensin II; Chronic Disease; Female; Glomerulonephritis; Humans; Indomethacin; Proteinuria | 1976 |
[A critical review of hypothetical causes of EPH-gestosis].
Topics: Aldosterone; Angiotensin II; Animals; Biogenic Amines; Blood Volume; Body Fluids; Edema; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypertension; Immunity; Kidney Diseases; Nutritional Physiological Phenomena; Placenta; Pre-Eclampsia; Pregnancy; Prostaglandins; Proteinuria; Renin; Uterus; Vasoconstrictor Agents | 1976 |
Effect of angiotensin on the filtration of protein in the rat kidney: a micropuncture study.
Topics: Angiotensin II; Animals; Kidney; Proteins; Proteinuria; Rats | 1975 |
Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy.
Topics: Adolescent; Adult; Angiotensin II; Animals; Blood Pressure; Dogs; Edema; Female; Gestational Age; Humans; Hypertension; Labor, Induced; Maternal Age; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Rabbits; Renin | 1975 |
Structural changes of the podocytes in different states of experimentally induced proteinuria in the rat.
Topics: Angiotensin II; Animals; Daunorubicin; Kidney Glomerulus; Microscopy, Electron, Scanning; Oxygen; Proteinuria; Rats; Serum Albumin | 1975 |
Effects of lisinopril on brain atrial natriuretic factor in uremic rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Dipeptides; Drinking; Hypothalamus; Lisinopril; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Sodium; Urine | 1992 |
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Creatinine; Glomerular Filtration Rate; Imidazoles; Kidney Glomerulus; Losartan; Male; Nephrectomy; Proteinuria; Punctures; Rats; Rats, Inbred Strains; Tetrazoles | 1992 |
Effect of cyclosporin A on proteinuria in patients with Alport's syndrome.
Topics: Adolescent; Angiotensin II; Basement Membrane; Child; Creatinine; Cyclosporine; Female; Humans; Kidney Function Tests; Kidney Glomerulus; Liver Function Tests; Male; Nephritis, Hereditary; Proteinuria | 1992 |
[The influence of hypertension and antihypertensive agents on experimental IgA nephropathy (IgAN)].
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Female; Glomerulonephritis, IGA; Hypertension, Renovascular; Kidney; Nifedipine; Proteinuria; Rats; Rats, Inbred Strains | 1991 |
[The mechanisms of exercise-induced proteinuria--relationship between urinary excretion of proteins and lactate after exhaustive exercise].
Topics: Adult; Angiotensin II; Capillaries; Catecholamines; Exercise; Humans; Kidney Glomerulus; Kidney Tubules; Lactates; Male; Proteins; Proteinuria | 1991 |
Prostaglandins, angiotension II, and proteinuria.
Topics: Angiotensin II; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Diet, Sodium-Restricted; Dinoprostone; Diuretics; Drug Synergism; Humans; Indomethacin; Kidney Glomerulus; Prostaglandin-Endoperoxide Synthases; Proteins; Proteinuria | 1990 |
Role for angiotensin II in an overt functional proteinuria.
Topics: Angiotensin II; Animals; Capillaries; Constriction; Dextrans; Glomerular Filtration Rate; Kidney Glomerulus; Molecular Weight; Pressure; Proteinuria; Rats; Rats, Inbred Strains; Renal Veins; Saralasin | 1986 |
Role of prostaglandins and angiotensin II in experimental glomerulonephritis.
Topics: Angiotensin II; Animals; Antibodies; Basement Membrane; Blood Pressure; Dinoprostone; Glomerulonephritis; Indomethacin; Kidney; Kidney Glomerulus; Prostaglandins; Prostaglandins E; Proteinuria; Rats; Saralasin; Vascular Resistance | 1985 |
Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules.
Topics: Angiotensin II; Animals; Glomerular Filtration Rate; Glomerular Mesangium; Immunoglobulin G; Infusions, Parenteral; Iodine Radioisotopes; Kidney Glomerulus; Liver; Male; Permeability; Proteinuria; Rats; Rats, Inbred Strains; Renal Circulation; Saralasin; Spleen | 1985 |
Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Estrogens; Female; Gestational Age; Humans; Hypertension; Parity; Placenta; Posture; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Renin; Sodium | 1973 |
[Nephrology].
Topics: Adult; Angiotensin II; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Pregnancy; Proteinuria; Renin; Transplantation, Homologous | 1966 |
Renal function during exercise. With special reference to exercise proteinuria and the release of renin.
Topics: Adult; Angiotensin II; Animals; Female; Glomerular Filtration Rate; Heart Rate; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Function Tests; Male; Physical Exertion; Potassium; Proteinuria; Rats; Renin; Sodium; Water-Electrolyte Balance | 1967 |
Hirano J, Masson GM: Effects of dietary sodium on hypertensive disease caused by renin.
Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Body Weight; Diet; Female; Hypertension, Renal; Kidney; Kidney Cortex Necrosis; Myocardium; Necrosis; Nephrectomy; Organ Size; Proteinuria; Rats; Renin; Sodium | 1968 |
Renin and erythropoietin in normotensive and in hypertensive patients.
Topics: Adolescent; Adult; Aged; Anemia; Angiotensin II; Blood Pressure; Blood Volume; Creatinine; Erythropoietin; Female; Hematocrit; Humans; Hypertension; Hypertension, Renal; Injections, Intravenous; Iron Isotopes; Male; Middle Aged; Potassium; Proteinuria; Renin; Sodium | 1968 |
[Proteinuria caused by angiotensin: electrophoretic study].
Topics: Angiotensin II; Animals; Electrophoresis; Proteinuria; Rats | 1968 |
[Plasma and urine renin concentration in patients with and without pathologic proteinuria].
Topics: Adult; Aged; Angiotensin II; Animals; Blood Pressure; Creatinine; Humans; Immunoelectrophoresis; Kidney; Methods; Middle Aged; Potassium; Proteinuria; Rats; Renin; Sodium | 1968 |
Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli.
Topics: Alkalosis; Angiotensin II; Blood Pressure; Carbon Dioxide; Cerebrospinal Fluid Proteins; Electrolytes; Female; Glycosuria; Humans; Hydrogen-Ion Concentration; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Infant; Infant, Newborn; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Magnesium; Male; Microscopy; Microscopy, Electron; Phosphorus; Proteinuria; Specific Gravity; Spironolactone | 1970 |
Note on some urinary components in exercise proteinuria. 1. Quantitative analyses of protein substances, polypeptides and-or amino acids. Biological analyses of urinary components.
Topics: Amino Acids; Angiotensin II; Animals; Biological Assay; Endopeptidases; Guinea Pigs; Humans; Kinins; Peptides; Physical Exertion; Proteinuria; Rabbits | 1970 |
The effect of renin, angiotensin II and adrenalectomy on glomerular capillary permeability in the rat.
Topics: Adrenal Glands; Adrenalectomy; Angiotensin II; Animals; Capillary Permeability; Corticosterone; Kidney Glomerulus; Povidone; Proteinuria; Rats; Renin | 1971 |
Antinatriuretic effect of intramuscular cadmium in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cadmium; Depression, Chemical; Female; Injections, Intramuscular; Natriuresis; Norepinephrine; Potassium; Proteinuria; Rats; Sodium | 1971 |
[Effect of preventive administration of reserpine on proteinuria induced with angiotensin in rats].
Topics: Angiotensin II; Animals; Hypertension; Proteinuria; Rats; Reserpine | 1971 |
A study of the inhibition of the renin-angiotensin system in renal potassium wasting syndromes, including Bartter's syndrome.
Topics: Adolescent; Alkalosis; Angiotensin II; Calcium; Child; Child, Preschool; Cystinosis; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Hypophosphatemia, Familial; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Proteinuria; Renin; Syndrome | 1972 |
Angiotensin, aldosterone and DOC in hypertensive disease of pregnancy.
Topics: Aldosterone; Angiotensin II; Desoxycorticosterone; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Radioimmunoassay; Renin | 1973 |
Plasma renin studies in patients with traumatic spinal cord injuries.
Topics: Adult; Angiotensin II; Creatinine; Diet, Sodium-Restricted; Humans; Hypertension; Male; Middle Aged; Paraplegia; Posture; Proteinuria; Pyelonephritis; Quadriplegia; Renin; Sodium; Sodium Chloride; Spinal Cord Injuries; Time Factors | 1973 |
A study of angiotensin II pressor response throughout primigravid pregnancy.
Topics: Adolescent; Angiotensin II; Blood Pressure; Eclampsia; Female; Humans; Hypertension; Injections, Intravenous; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Vascular Resistance | 1973 |
Urinary angiotensinogen loss in chronic proteinuric glomerulonephritis.
Topics: Angiotensin II; Glomerulonephritis; Humans; Immunodiffusion; Immunoglobulin G; Molecular Weight; Proteinuria; Transferrin | 1972 |
[Proteinuria caused by angiotensin: blood protein clearance].
Topics: Angiotensin II; Animals; Blood Pressure; Blood Proteins; Hypertension; Proteinuria; Rats | 1973 |
The effect of exogenous angiotensin on superficial and deep glomeruli in the rat kidney.
Topics: Angiotensin II; Animals; Capillaries; Epithelial Cells; Immune Sera; Infusions, Parenteral; Kidney Glomerulus; Male; Microscopy, Electron; Phentolamine; Proteinuria; Rats; Sodium Chloride | 1972 |
Proceedings: Angiotensin II levels in normal and hypertensive primigravid pregnancy.
Topics: Angiotensin II; Blood Pressure; Edema; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Proteinuria | 1974 |
Renin induced proteinuria and the effects of adrenalectomy. I. Haemodynamic changes in relation to function.
Topics: Adrenal Glands; Adrenalectomy; Angiotensin II; Animals; Blood Pressure; Epinephrine; Hemodynamics; Kidney; Male; Norepinephrine; Proteinuria; Rats; Renin; Swine | 1972 |
Renin induced proteinuria and the effects of adrenalectomy. II. Morphology in relation to function.
Topics: Adrenal Glands; Adrenalectomy; Angiotensin II; Animals; Kidney; Kidney Function Tests; Male; Microscopy, Electron; Proteinuria; Rats; Renin; Swine | 1972 |